Glac Biotech is the most innovative and leading probiotic and Postbiotics manufacturer in Asia. We not only focus on the nutraceutical and food markets, but specialize in developing, manufacturing, and marketing advanced probiotics and Postbiotics researches and applications as well. Since the establishment in 2008, Glac Biotech keeps continuously developing clinically proven probiotics and Postbiotics to fit the trend of healthcare market with great ambition of becoming the leading biotech company in the world. Glac Biotech has two manufacturing facilities in Tainan city and Chiayi city with Taiwan FDA GMP, HALAL, ISO, and HACCP certificates and provides one-stop service solution to business partners. Regarding research and development, we’ve developed more than 1,000 probiotic strains with screening and identifying each function of strains, so we can build up our product portfolio and conduct clinical studies. On top of that, the areas of clinical studies cover gut health, stomach care, allergy relief, vagina health, oral care, sleep support, uric acid management, glucose control, weight management, and so on. These studies not only support the efficacy of our blends, but also make our probiotics stand out among competition. Not to mention, our Totipro® Postbiotics PE0401, which is could be the next generation of probiotics and the future of gut health and helps support the immune system and positively modulate the gut microbiome. The features of Postbiotics are not only heat stable, but also wide range of food and beverage applications, full of nutrients, and friendly room temperature storage. New Dietary Ingredients status with US FDA could be received in 2023. With our high quality production technologies and proven efficacy of functional probiotics and Postbiotics, we assure our business partner will have a tremendous and fruitful business with us.